Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-21-000004

CFO sold 30,000 shares at $10.02 ($300,558)

  • CFO acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KIES PETER · CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-15 Exercise or conversion : show line 1 in the form +30,000 $4.56 $136,800 149,290 D
2021-01-15 Sale : show line 2 in the form −30,000 $10.02 $300,558 119,290 D
Open-market sales · 30,000 sh · avg $10.02 · $300,558

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-15 Exercise or conversion : show line 3 in the form Common Stock Option −30,000 0 D
Loading xslF345X03/wf-form4_161075672601972.xml…